- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.01. | GSK reaches $2.2bn deal to buy food allergy biotech RAPT | ||
| 19.01. | Sun Pharma says talk of $10bn Organon bid is 'speculative' | ||
| 19.01. | EU starts review of first-line Enhertu for breast cancer | ||
| 19.01. | Could Alzheimer's be predicted with a finger-prick test? | ||
| 19.01. | NICE relents, ending postcode access to prostate cancer drug | ||
| 19.01. | 'Skinny' generic Vascepa label case reaches US Supreme Court | ||
| 16.01. | Wegovy pill shows strong early uptake, as rival looms | ||
| 16.01. | Sanofi linked to takeover bid for Ocular Therapeutix | ||
| 16.01. | Ocugen shares fall, despite positive eye disorder trial | ||
| 16.01. | Autonomous AI can spot cognitive decline in medical notes | ||
| 16.01. | Trump's affordability plan arrives, built around MFN pricing | ||
| 15.01. | J&J builds case for earlier Tecvayli use in multiple myeloma | ||
| 15.01. | Novartis issues a life sciences warning in a 'G-Zero' world | ||
| 15.01. | Novo Nordisk Foundation pledges €736m for European biotech | ||
| 15.01. | EMA and FDA agree 'principles' for AI in drug development | ||
| 15.01. | Oxford BioMedica confirms private equity takeover talks | ||
| 14.01. | JPM: Novo Nordisk CEO gives insight into new strategy | ||
| 14.01. | FDA seeks changes to GLP-1, flu shot labels | ||
| 14.01. | Hippocratic AI builds in life sciences with Grove AI buy | ||
| 14.01. | JPM: Illumina launches 'unprecedented' disease biology atlas | ||
| 14.01. | UK names health data chief, as BIA finds its new CEO | ||
| 13.01. | JPM: Anthropic reveals its answer to ChatGPT for Health | ||
| 13.01. | Sentynl gets first FDA approval for rare disease Menkes | ||
| 13.01. | AbbVie turbocharges its US investment promise to $100bn | ||
| 13.01. | JPM: Is the UK's clinical trials sector turning a corner? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.